Man GLG Pan-European Equity Growth Class IV C USDRegistreer u om de ratings zichtbaar te maken |
Hoe heeft dit fonds gepresteerd? | 31/05/2024 |
Ontwikkeling van EUR 1000 (EUR) | Uitgebreide Grafiek |
Fonds | 20,6 | 18,0 | -25,9 | 20,8 | 7,9 | |
+/-Cat | 12,1 | -6,5 | -5,4 | 4,6 | 0,2 | |
+/-Idx | - | - | - | 4,6 | -2,9 | |
Categorie: Aandelen Europa Large-Cap Groei | ||||||
Benchmark: Morningstar DM Europe Grt T... |
Kerngegevens | ||
Koers 13/06/2024 | USD 115,04 | |
Rendement 1 Dag | -1,31% | |
Morningstar Categorie™ | Aandelen Europa Large-Cap Groei | |
ISIN | IE00BMG8V088 | |
Grootte Fonds (Mil) 13/06/2024 | EUR 299,65 | |
Grootte Fondsklasse (Mil) 13/06/2024 | USD 0,35 | |
Aankoopkosten (Max) | 5,00% | |
Lopende Kosten Factor 03/06/2024 | 1,20% | |
Gesloten voor nieuwe beleggers | nee |
Beleggingsdoelstelling: Man GLG Pan-European Equity Growth Class IV C USD |
The Portfolio’s investment objective is to provide medium to long term capital appreciation. The Portfolio will seek to outperform the MSCI Europe Total Return Net Dividend (the “Benchmark”). The Portfolio will invest all or part of the net proceeds of Shares in (i) transferable securities (ii) exchange traded and OTC financial derivative instruments, (iii) money market instruments, (iv) other collective investment schemes and (v) deposits, cash or cash equivalents. At least 51% of the value of the Portfolio will be invested on an ongoing basis in holdings in equity securities that are authorised for official trading on a stock exchange or included in an organised market. |
Returns | |||||||||||||
|
Management | ||
Naam manager Aanvangsdatum | ||
Virginia Nordback 20/11/2018 | ||
Rory Powe 02/12/2016 | ||
Oprichtingsdatum 13/11/2020 |
Advertentie |
Benchmark | |
Benchmark van het fonds | Benchmark Morningstar |
MSCI Europe NR EUR | Morningstar DM Europe Grt TME NR EUR |
Target Market | ||||||||||||||||||||
|
Waar belegt het fonds in? Man GLG Pan-European Equity Growth Class IV C USD | 30/04/2024 |
|
|
Top 5 posities | Sector | % |
Novo Nordisk A/S Class B | Gezondheidszorg | 9,59 |
L'Oreal SA | Defensieve Consumptiegoederen | 7,29 |
Ryanair Holdings PLC | Industrie | 7,23 |
ASML Holding NV | Technologie | 7,02 |
Lvmh Moet Hennessy Louis Vuitton SE | Cyclische Consumptiegoederen | 6,78 |
Toename Afname Nieuw t.o.v. vorige portefeuille | ||
Man GLG Pan-European Equity Growth Class IV C USD |